Atlas Trials

Impact of Human Papillomavirus (HPV) Vaccination on Burden of Disease in Patients with Actinic Keratosis

Clinical trial NCT05202860 · ACTIVE_NOT_RECRUITING

Trial details

NCT number
NCT05202860
Sponsor
Merete Haedersdal
Status
ACTIVE_NOT_RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Actinic KeratosesBasal Cell CarcinomaSquamous Cell Carcinoma
Start date
2022-05-09
Primary completion
2024-06-19
Enrollment
70

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.